Ranbaxy gets nod to sell anti-schizophrenia drug Economic Times, India "The company has received an approval from the Therapeutic Goods Administration (TGA), Department of Health & Ageing of the Australian government, for the registration of Ozidal Risperidone 0.5, 1, 2, 3 and 4 mg tablets in Australia. ... Ranbaxy gets Australia nod for antipsychotic drug Ranbaxy receives approval for OZIDAL Risperidone Tablets from TGA ... Ranbaxy: gets Australia nod for antipsychotic drug |
Tuesday, March 24, 2009
Ranbaxy gets nod to sell anti-schizophrenia drug - Economic Times
Read More
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment